A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Fisker, Ane BNebie, Eric
Schoeps, Anja
Martins, Cesario
Rodrigues, Amabelia
Zakane, Alphonse
Kagone, Moubassira
Byberg, Stine
Thysen, Sanne M
Tiendrebeogo, Justin
Coulibaly, Boubacar
Sankoh, Osman
Becher, Heiko
Whittle, Hilton C
van der Klis, Fiona R M
Benn, Christine S
Sie, Ali
Müller, Olaf
Aaby, Peter
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.Published in
Clin Infect Dis 2018; 66(10):1573-80Publiekssamenvatting
Besides protecting against measles, measles vaccine (MV) may have beneficial non-specific effects. We tested the effect of an additional early MV on mortality and measles antibody levels.PMID
29177407ae974a485f413a2113503eed53cd6c53
10.1093/cid/cix1033
Scopus Count
Collections